XML 20 R9.htm IDEA: XBRL DOCUMENT
v3.23.2

Adoption of ASU 2018-12 | 6 Months Ended
--- | ---
Jun. 30, 2023
Adoption of ASU 2018-12 [Abstract] |
Adoption of ASU 2018-12 | 3. Adoption of ASU 2018-12 On January 1, 2023, we adopted FASB ASU 2018-12, Targeted Improvements to the Accounting for Long-Duration Contracts and related amendments (“ASU 2018-12”) with a transition date of January 1, 2021. ASU 2018-12 updated accounting and reporting requirements for long-duration contracts and certain investment contracts issued by insurance entities. We adopted ASU 2018-12 under the modified retrospective approach, except for MRBs, which applied the full retrospective approach. Our consolidated financial statements are presented under the new guidance for reporting periods beginning January 1, 2021. Under ASU 2018-12, we include actual historical cash flows along with best estimate future cash flows to derive the net premium ratio when calculating the LFPB associated with our traditional and limited-payment long-duration contracts. We review and update, if necessary, assumptions used to measure future cash flows included in the net premium ratio at least annually. Historical cash flows included in the net premium ratio are updated for actual experience quarterly and as assumptions are updated. Changes in the measurement of our LFPB result from updates to cash flow assumptions and actual experience, which impacts are reported within policyholder remeasurement gain (loss) on our Consolidated Statements of Comprehensive Income (Loss). We use an upper-medium grade (low credit risk) fixed-income instrument yield (single-A) discount rate when calculating the LFPB. This discount rate is updated quarterly at each reporting date with the impact recognized in OCI. ASU 2018-12 also eliminated loss recognition testing, premium deficiency testing and the provision for adverse deviation for LFPB. ASU 2018-12 introduced the category of MRBs, which are contracts or contract features that provide protection to the policyholder from other-than-nominal capital market risk and expose us to other-than-nominal capital market risk upon the occurrence of a specific event or circumstance, such as death, annuitization or periodic withdrawal. MRBs are required to be measured at fair value, with periodic changes in fair value reported within MRB gain (loss) on our Consolidated Statements of Comprehensive Income (Loss), except for periodic changes to instrument-specific credit risk related to direct policies, which are recognized in OCI. Changes in the fair value of ceded MRB assets and liabilities are also reported within MRB gain (loss) on our Consolidated Statements of Comprehensive Income (Loss). ASU 2018-12 simplified the amortization model for DAC and DAC-like intangible balances, including VOBA, DSI and DFEL. Historically these balances were amortized in proportion to premium or over expected gross profits. They are now amortized on a constant-level basis over the expected term of the contract. Loss recognition testing and impairment testing are no longer applicable for DAC. ASU 2018-12 requires disaggregated rollforwards of the beginning of year to the end of the reporting period balances. We also disclose information about inputs, judgments, assumptions, methods, changes during the period and the effect of these changes on the measurement of applicable balances. In determining the appropriate level of aggregation, we considered our reportable segments, nature and risk characteristics of our products and level of aggregation we used in disclosures presented outside the financial statements. The following table presents the cumulative effect adjustments (in millions), after-tax and shown as increase (decrease), to the components of stockholders’ equity due to the adoption of ASU 2018-12 as of January 1, 2021, by primary accounting topic:
|  |  |  |  | Total |
| Retained |  |  |  | Stockholders’ |
| Earnings |  | AOCI |  | Equity |
Shadow impacts: |  |  |  |  |  |  |  |  |
DAC, VOBA, DSI and DFEL | $ | - |  | $ | 2,271 |  | $ | 2,271 |
Additional liabilities for other |  |  |  |  |  |  |  |  |
insurance benefits |  | - |  |  | 1,197 |  |  | 1,197 |
LFPB and other (1) |  | (187 | ) |  | (1,715 | ) |  | (1,902 | )
MRBs (2) |  | (6,086 | ) |  | 2,874 |  |  | (3,212 | )
Total | $ | (6,273 | ) | $ | 4,627 |  | $ | (1,646 | )
(1)Includes impacts to reserves and ceded reserves reported within future contract benefits and reinsurance recoverables, respectively on the Consolidated Balance Sheets, excluding shadow impacts on additional liabilities for other insurance benefits. (2)Includes impacts related to MRB assets and MRB liabilities reported on the Consolidated Balance Sheets, and ceded MRBs reported within other assets on the Consolidated Balance Sheets. ‎ The following table summarizes the effect of the adoption of ASU 2018-12 as of January 1, 2021, (in millions) on the Consolidated Balance Sheets:
|  |  |  |  | Total |
| Retained |  |  |  | Stockholders’ |
| Earnings |  | AOCI |  | Equity |
DAC, VOBA and DSI | $ | - |  | $ | 6,079 |  | $ | 6,079 |
Reinsurance recoverables |  | 607 |  |  | 2,431 |  |  | 3,038 |
Other assets (1) |  | 242 |  |  | - |  |  | 242 |
Future contract benefits |  | (844 | ) |  | (3,088 | ) |  | (3,932 | )
MRBs, net |  | (7,956 | ) |  | 3,656 |  |  | (4,300 | )
DFEL |  | - |  |  | (3,190 | ) |  | (3,190 | )
Other liabilities (2) |  | 1,678 |  |  | (1,261 | ) |  | 417 |
Total | $ | (6,273 | ) | $ | 4,627 |  | $ | (1,646 | )
(1)Consists primarily of ceded MRB adjustments. (2)Consists of state and federal tax adjustments. The following table summarizes the changes in DAC, VOBA and DSI, pre-tax, (in millions) due to the adoption of ASU 2018-12 and reconciles this balance to the Consolidated Balance Sheets:
|  |  | Impact from |  |  |
| Balance |  | Removal of |  | Balance |
| Pre-Adoption |  | Shadow |  | Post-Adoption |
| December 31, |  | Balances |  | January 1, |
| 2020 |  | from AOCI |  | 2021 |
DAC |  |  |  |  |  |  |  |  |
Traditional Life | $ | 1,082 |  | $ | - |  | $ | 1,082 |
UL and Other |  | 394 |  |  | 5,031 |  |  | 5,425 |
Variable Annuities |  | 3,518 |  |  | 52 |  |  | 3,570 |
Fixed Annuities |  | 264 |  |  | 215 |  |  | 479 |
Group Protection |  | 187 |  |  | - |  |  | 187 |
Retirement Plan Services |  | 120 |  |  | 112 |  |  | 232 |
Total DAC |  | 5,565 |  |  | 5,410 |  |  | 10,975 |
VOBA |  |  |  |  |  |  |  |  |
Traditional Life |  | 67 |  |  | - |  |  | 67 |
UL and Other |  | 180 |  |  | 630 |  |  | 810 |
Fixed Annuities |  | - |  |  | 23 |  |  | 23 |
Total VOBA |  | 247 |  |  | 653 |  |  | 900 |
DSI (1) |  |  |  |  |  |  |  |  |
UL and Other |  | 35 |  |  | - |  |  | 35 |
Variable Annuities |  | 148 |  |  | 2 |  |  | 150 |
Fixed Annuities |  | 17 |  |  | 13 |  |  | 30 |
Retirement Plan Services |  | 13 |  |  | 1 |  |  | 14 |
Total DSI |  | 213 |  |  | 16 |  |  | 229 |
Total DAC, VOBA and DSI | $ | 6,025 |  | $ | 6,079 |  | $ | 12,104 |
(1)Pre-adoption DSI balance was previously reported in other assets on the Consolidated Balance Sheets. ‎ The following table summarizes the changes in DFEL, pre-tax, (in millions) due to the adoption of ASU 2018-12 and reconciles this balance to the Consolidated Balance Sheets:
|  |  |  | Impact from |  |  |  |
| Balance |  | Removal of |  | Balance |
| Pre-Adoption |  | Shadow |  | Post-Adoption |
| December 31, |  | Balances |  | January 1, |
| 2020 |  | from AOCI |  | 2021 |
DFEL (1) |  |  |  |  |  |  |  |  |
UL and Other | $ | 113 |  | $ | 3,185 |  | $ | 3,298 |
Variable Annuities |  | 288 |  |  | 5 |  |  | 293 |
Total DFEL | $ | 401 |  | $ | 3,190 |  | $ | 3,591 |
(1)Pre-adoption DFEL balance was previously reported in other contract holder funds on the Consolidated Balance Sheets. The following table summarizes the changes in future contract benefits, pre-tax, (in millions) due to the adoption of ASU 2018-12 and reconciles this balance to the Consolidated Balance Sheets:
|  |  |  | Impact from |  | Single-A |  |  |  |  |  |  |
| Balance |  | Removal of |  | Discount |  | Cumulative |  | Balance |
| Pre-Adoption |  | Shadow |  | Rate |  | Effect to |  | Post-Adoption |
| December 31, |  | Balances |  | Measurement |  | Retained |  | January 1, |
| 2020 (1) |  | from AOCI |  | in AOCI |  | Earnings |  | 2021 |
LFPB |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Traditional Life | $ | 3,483 |  | $ | - |  | $ | 943 |  | $ | - |  | $ | 4,426 |
Payout Annuities |  | 2,314 |  |  | (105 | ) |  | 415 |  |  | 44 |  |  | 2,668 |
Liability for Future Claims |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Group Protection |  | 5,422 |  |  | - |  |  | 517 |  |  | - |  |  | 5,939 |
Additional Liabilities for Other |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Insurance Benefits |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
UL and Other |  | 13,649 |  |  | (1,515 | ) |  | - |  |  | 174 |  |  | 12,308 |
Other Operations (2) |  | 10,463 |  |  | (80 | ) |  | 2,913 |  |  | 626 |  |  | 13,922 |
Other (3) |  | 3,565 |  |  | - |  |  | - |  |  | - |  |  | 3,565 |
Total future contract benefits | $ | 38,896 |  | $ | (1,700 | ) | $ | 4,788 |  | $ | 844 |  | $ | 42,828 |
(1)Balance pre-adoption excludes features that meet the definition of an MRB upon transition, including features that were previously accounted for as an additional liability. Also, balance pre-adoption reflects certain reclassifications of non-life contingent account balances from future contract benefits to policyholder account balances within the Consolidated Balance Sheets. (2)Represents future contract benefits reported in Other Operations primarily attributable to the indemnity reinsurance agreements with Protective ($6.3 billion and $7.4 billion as of December 31, 2020, and January 1, 2021, respectively) and Swiss Re ($2.0 billion and $3.5 billion as of December 31, 2020, and January 1, 2021, respectively). Includes LFPB and additional liabilities balances. (3)Represents other miscellaneous reserves outside the scope of ASU 2018-12. ‎ The following table summarizes the changes in reinsurance recoverables, pre-tax, (in millions) due to the adoption of ASU 2018-12 and reconciles this balance to the Consolidated Balance Sheets:
|  |  |  | Single-A |  |  |  |  |  |  |
| Balance |  | Discount |  | Cumulative |  | Balance |
| Pre-Adoption |  | Rate |  | Effect to |  | Post-Adoption |
| December 31, |  | Measurement |  | Retained |  | January 1, |
| 2020 (1) |  | in AOCI |  | Earnings |  | 2021 |
Reinsured LFPB |  |  |  |  |  |  |  |  |  |  |  |
Traditional Life | $ | 755 |  | $ | 151 |  | $ | - |  | $ | 906 |
Payout Annuities |  | 2 |  |  | - |  |  | - |  |  | 2 |
Reinsured Liability for Future |  |  |  |  |  |  |  |  |  |  |  |
Claims |  |  |  |  |  |  |  |  |  |  |  |
Group Protection |  | 148 |  |  | 14 |  |  | - |  |  | 162 |
Reinsured Additional Liabilities |  |  |  |  |  |  |  |  |  |  |  |
for Other Insurance Benefits |  |  |  |  |  |  |  |  |  |  |  |
UL and Other |  | 335 |  |  | - |  |  | (3 | ) |  | 332 |
Reinsured Other Operations (2) |  | 14,320 |  |  | 2,266 |  |  | 610 |  |  | 17,196 |
Reinsured Other (3) |  | 790 |  |  | - |  |  | - |  |  | 790 |
Total reinsurance recoverables | $ | 16,350 |  | $ | 2,431 |  | $ | 607 |  | $ | 19,388 |
(1)Balance pre-adoption excludes features that meet the definition of a ceded MRB upon transition, including features that were previously accounted for as reinsured additional liabilities. (2)Represents reinsurance recoverables reported in Other Operations primarily attributable to the indemnity reinsurance agreements with Protective ($12.0 billion and $13.2 billion as of December 31, 2020, and January 1, 2021, respectively) and Swiss Re ($1.3 billion and $2.6 billion as of December 31, 2020, and January 1, 2021, respectively). Includes reinsured LFPB and reinsured additional liabilities balances. (3)Represents other miscellaneous reinsurance recoverables outside the scope of ASU 2018-12. The following table summarizes the changes in the net liability position of MRBs, pre-tax, (in millions) due to the adoption of ASU 2018-12 and reconciles this balance to the Consolidated Balance Sheets:
| Balance |  | Cumulative |  | Cumulative |  | Balance |
| Pre-Adoption |  | Effect of |  | Effect to |  | Post-Adoption |
| December 31, |  | Credit Risk |  | Retained |  | January 1, |
| 2020 (1) |  | to AOCI |  | Earnings |  | 2021 |
MRBs, Net |  |  |  |  |  |  |  |  |  |  |  |
Variable Annuities | $ | 831 |  | $ | (3,592 | ) | $ | 7,968 |  | $ | 5,207 |
Fixed Annuities |  | 192 |  |  | (52 | ) |  | (22 | ) |  | 118 |
Retirement Plan Services |  | 11 |  |  | (12 | ) |  | 10 |  |  | 9 |
Total MRBs, net | $ | 1,034 |  | $ | (3,656 | ) | $ | 7,956 |  | $ | 5,334 |
(1)Balance pre-adoption includes all features that meet the definition of an MRB upon transition, including features that were previously accounted for as additional liabilities or embedded derivatives. ‎ The following table summarizes the changes in the net asset position of ceded MRBs, pre-tax, (in millions) due to the adoption of ASU 2018-12, reported in other assets on the Consolidated Balance Sheets:
| Balance |  | Cumulative |  | Balance |
| Pre-Adoption |  | Effect to |  | Post-Adoption |
| December 31, |  | Retained |  | January 1, |
| 2020 (1) |  | Earnings |  | 2021 |
Ceded MRBs, Net |  |  |  |  |  |  |  |  |
Variable Annuities | $ | 215 |  | $ | 121 |  | $ | 336 |
Total ceded MRBs, net | $ | 215 |  | $ | 121 |  | $ | 336 |
(1)Balance pre-adoption includes all features that meet the definition of a ceded MRB upon transition, including features that were previously accounted for as reinsured additional liabilities or embedded derivatives. The following summarizes the effect of the adoption of ASU 2018-12 (in millions) on certain financial statement line items within the previously reported Consolidated Balance Sheets:
| As of December 31, 2022 |
|  |  | Adoption |  |  |  |
| As |  | of New |  |  |  |
| Previously |  | Accounting |  | As |
| Reported (1) |  | Standard |  | Adjusted |
Deferred acquisition costs, value of business acquired and |  |  |  |  |  |  |  |  |
deferred sales inducements (2) | $ | 13,803 |  | $ | (1,568 | ) | $ | 12,235 |
Reinsurance recoverables, net of allowance for credit losses |  | 19,882 |  |  | (439 | ) |  | 19,443 |
Market risk benefit assets |  | - |  |  | 2,807 |  |  | 2,807 |
Other assets (2) |  | 20,493 |  |  | (1,691 | ) |  | 18,802 |
Total assets |  | 335,108 |  |  | (891 | ) |  | 334,217 |
Future contract benefits (2) |  | 41,756 |  |  | (2,930 | ) |  | 38,826 |
Market risk benefit liabilities |  | - |  |  | 2,078 |  |  | 2,078 |
Deferred front-end loads (2) |  | 5,669 |  |  | (617 | ) |  | 5,052 |
Other liabilities (2) |  | 11,976 |  |  | 45 |  |  | 12,021 |
Total liabilities |  | 330,539 |  |  | (1,424 | ) |  | 329,115 |
Retained earnings |  | 6,707 |  |  | (783 | ) |  | 5,924 |
Accumulated other comprehensive income (loss) |  | (7,668 | ) |  | 1,316 |  |  | (6,352 | )
Total stockholders’ equity |  | 4,569 |  |  | 533 |  |  | 5,102 |
(1)The amounts as previously reported were derived from Note 1 in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K. (2)Certain amounts have been reclassified to conform to the presentation adopted in the current period. ‎ The following summarizes the effect of the adoption of ASU 2018-12 (in millions) on certain financial statement line items within the previously reported Consolidated Statements of Comprehensive Income (Loss):
| For the Three Months Ended June 30, 2022
|  |  | Adoption |  |  |  |
| As |  | of New |  |  |  |
| Previously |  | Accounting |  | As |
| Reported (1) |  | Standard |  | Adjusted |
Fee income | $ | 1,506 |  | $ | (97 | ) | $ | 1,409 |
Realized gain (loss) |  | 515 |  |  | 586 |  |  | 1,101 |
Total revenues |  | 5,088 |  |  | 489 |  |  | 5,577 |
Benefits |  | 2,890 |  |  | (936 | ) |  | 1,954 |
Interest credited |  | 706 |  |  | 4 |  |  | 710 |
Market risk benefit (gain) loss |  | - |  |  | 477 |  |  | 477 |
Policyholder liability remeasurement (gain) loss |  | - |  |  | 85 |  |  | 85 |
Commissions and other expenses |  | 1,123 |  |  | 84 |  |  | 1,207 |
Total expenses |  | 4,831 |  |  | (286 | ) |  | 4,545 |
Income (loss) before taxes |  | 257 |  |  | 775 |  |  | 1,032 |
Federal income tax expense (benefit) |  | 29 |  |  | 163 |  |  | 192 |
Net income (loss) |  | 228 |  |  | 612 |  |  | 840 |
Unrealized investment gain (loss) |  | (5,585 | ) |  | (1,070 | ) |  | (6,655 | )
Market risk benefit non-performance risk gain (loss) |  | - |  |  | 354 |  |  | 354 |
Policyholder liability discount rate remeasurement gain (loss) |  | - |  |  | 710 |  |  | 710 |
Total other comprehensive income (loss), net of tax |  | (5,589 | ) |  | (6 | ) |  | (5,595 | )
Comprehensive income (loss) |  | (5,361 | ) |  | 606 |  |  | (4,755 | )
Net income (loss) per common share: |  |  |  |  |  |  |  |  |
Basic |  | 1.34 |  |  | 3.57 |  |  | 4.91 |
Diluted |  | 1.28 |  |  | 3.55 |  |  | 4.83 |
| For the Six Months Ended June 30, 2022
|  |  | Adoption |  |  |  |
| As |  | of New |  |  |  |
| Previously |  | Accounting |  | As |
| Reported (1) |  | Standard |  | Adjusted |
Fee income | $ | 3,074 |  | $ | (207 | ) | $ | 2,867 |
Realized gain (loss) |  | 540 |  |  | 742 |  |  | 1,282 |
Total revenues |  | 9,762 |  |  | 535 |  |  | 10,297 |
Benefits |  | 5,458 |  |  | (1,348 | ) |  | 4,110 |
Interest credited |  | 1,403 |  |  | 4 |  |  | 1,407 |
Market risk benefit (gain) loss |  | - |  |  | (881 | ) |  | (881 | )
Policyholder liability remeasurement (gain) loss |  | - |  |  | 126 |  |  | 126 |
Commissions and other expenses |  | 2,358 |  |  | 102 |  |  | 2,460 |
Total expenses |  | 9,428 |  |  | (1,997 | ) |  | 7,431 |
Income (loss) before taxes |  | 334 |  |  | 2,532 |  |  | 2,866 |
Federal income tax expense (benefit) |  | 15 |  |  | 530 |  |  | 545 |
Net income (loss) |  | 319 |  |  | 2,002 |  |  | 2,321 |
Unrealized investment gain (loss) |  | (10,772 | ) |  | (3,381 | ) |  | (14,153 | )
Market risk benefit non-performance risk gain (loss) |  | - |  |  | 374 |  |  | 374 |
Policyholder liability discount rate remeasurement gain (loss) |  | - |  |  | 1,521 |  |  | 1,521 |
Total other comprehensive income (loss), net of tax |  | (10,778 | ) |  | (1,486 | ) |  | (12,264 | )
Comprehensive income (loss) |  | (10,458 | ) |  | 515 |  |  | (9,943 | )
Net income (loss) per common share: |  |  |  |  |  |  |  |  |
Basic |  | 1.87 |  |  | 11.57 |  |  | 13.44 |
Diluted |  | 1.80 |  |  | 11.45 |  |  | 13.25 |
(1)The amounts as previously reported were derived from Note 23 in our 2022 Form 10-K/A. The following summarizes the effect of the adoption of ASU 2018-12 (in millions) on certain financial statement line items within the previously reported Consolidated Statements of Stockholders’ Equity:
| For the Three Months Ended June 30, 2022
|  |  | Adoption |  |  |  |
| As |  | of New |  |  |  |
| Previously |  | Accounting |  | As |
| Reported (1) |  | Standard |  | Adjusted |
Retained earnings balance as of beginning-of-period | $ | 9,346 |  | $ | (2,992 | ) | $ | 6,354 |
Net income (loss) |  | 228 |  |  | 612 |  |  | 840 |
Retained earnings balance as of end-of-period |  | 9,445 |  |  | (2,380 | ) |  | 7,065 |
Accumulated other comprehensive income (loss) balance |  |  |  |  |  |  |  |  |
as of beginning-of-period |  | 1,252 |  |  | 2,063 |  |  | 3,315 |
Other comprehensive income (loss), net of tax |  | (5,589 | ) |  | (6 | ) |  | (5,595 | )
Accumulated other comprehensive income (loss) balance |  |  |  |  |  |  |  |  |
as of end-of-period |  | (4,337 | ) |  | 2,057 |  |  | (2,280 | )
Total stockholders’ equity as of end-of-period |  | 9,654 |  |  | (323 | ) |  | 9,331 |
| For the Six Months Ended June 30, 2022
|  |  | Adoption |  |  |  |
| As |  | of New |  |  |  |
| Previously |  | Accounting |  | As |
| Reported (1) |  | Standard |  | Adjusted |
Retained earnings balance as of beginning-of-year | $ | 9,578 |  | $ | (4,382 | ) | $ | 5,196 |
Net income (loss) |  | 319 |  |  | 2,002 |  |  | 2,321 |
Retained earnings balance as of end-of-period |  | 9,445 |  |  | (2,380 | ) |  | 7,065 |
Accumulated other comprehensive income (loss) balance |  |  |  |  |  |  |  |  |
as of beginning-of-year |  | 6,441 |  |  | 3,543 |  |  | 9,984 |
Other comprehensive income (loss), net of tax |  | (10,778 | ) |  | (1,486 | ) |  | (12,264 | )
Accumulated other comprehensive income (loss) balance |  |  |  |  |  |  |  |  |
as of end-of-period |  | (4,337 | ) |  | 2,057 |  |  | (2,280 | )
Total stockholders’ equity as of end-of-period |  | 9,654 |  |  | (323 | ) |  | 9,331 |
(1)The amounts as previously reported were derived from Note 23 in our 2022 Form 10-K/A. The following summarizes the effect of the adoption of ASU 2018-12 (in millions) on certain financial statement line items within the previously reported Consolidated Statements of Cash Flows:
| For the Six Months Ended June 30, 2022
|  |  | Adoption |  |  |  |
| As |  | of New |  |  |  |
| Previously |  | Accounting |  | As |
| Reported (1) |  | Standard |  | Adjusted |
Net income (loss) | $ | 319 |  | $ | 2,002 |  | $ | 2,321 |
Adjustments to reconcile net income (loss) to net cash provided by (used in) |  |  |  |  |  |  |  |  |
operating activities: |  |  |  |  |  |  |  |  |
Realized (gain) loss |  | (540 | ) |  | (742 | ) |  | (1,282 | )
Market risk benefit (gain) loss |  | - |  |  | (881 | ) |  | (881 | )
Change in: |  |  |  |  |  |  |  |  |
Deferred acquisition costs, value of business acquired, deferred sales |  |  |  |  |  |  |  |  |
inducements and deferred front-end loads |  | - |  |  | 244 |  |  | 244 |
Insurance liabilities and reinsurance-related balances (2) |  | 2,837 |  |  | (1,167 | ) |  | 1,670 |
Accrued expenses |  | (371 | ) |  | (4 | ) |  | (375 | )
Federal income tax accruals |  | 69 |  |  | 530 |  |  | 599 |
Other (2) |  | (4 | ) |  | 18 |  |  | 14 |
(1)The amounts as previously reported were derived from Note 23 in our 2022 Form 10-K/A. (2)Certain amounts have been reclassified to conform to the presentation adopted in the current period.

X
- References No definition available. + Details
Name: | us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479838/944-20-50-7 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//944/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 310 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c)(4)(ii) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479584/944-310-50-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 310 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c)(4)(iv) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479584/944-310-50-3 + Details
Name: | us-gaap_InsuranceDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration